Histology and Molecular Markers in NSCLC
Links shared publicly online about this topic.
- 0total visits
Histology and Molecular Markers in NSCLC
View full resource at accc-cancer.org
Tags: Cancer, Non-Small Cell Lung Cancer, Exercise and Fitness, Running, Oncologist, Oncology, Education
Most Recently Shared on February 8, 2012 at 7:10 pm By:
Do you or your colleagues treat patients with NSCLC? We're seeking participants for new initiative beginning in March http://t.co/HQ4C5rtK
Also Shared By:
GRACE :: Lung Cancer» Blog Archive » Upcoming Webinar on Molecular Markers in Advanced NSCLC: Who to Test and What to Test For?
cancergrace.org — “GRACE :: Lung Cancer» Blog Archive » Upcoming Webinar on Molecular Markers in Advanced NSCLC: Who to Test and What to Test For?” View full resource at cancergrace.org
Most Recently Shared on January 25, 2012 at 5:19 am By:
H. Jack West, MD Physician, Doctor, Internist, Health Executive, and Oncologist
Feb 22nd free @CancerGRACE & @LUNGevity-sponsored panel discuss'n, webinar w/4 great #LungCancer docs on molec testing: http://t.co/AF0jwTup
Entinostat plus erlotinib improves survival in NSCLC patients with elevated E-cadherin
news-medical.net — “Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).” View full resource at news-medical.net
Most Recently Shared on December 10, 2010 at 3:41 pm By:
Lung Cancer News: Entinostat plus erlotinib improves survival in NSCLC patients with elevated E-cadherin: Syndax... http://bit.ly/gd9lpo
WEBINAR: What should our standard be for molecular marker testing in NSCLC today
events.constantcontact.com — “WEBINAR: What should our standard be for molecular marker testing in NSCLC today” View full resource at events.constantcontact.com
Most Recently Shared on April 2, 2010 at 1:28 pm By:
H. Jack West, MD Physician, Doctor, Internist, Health Executive, and Oncologist
Timely, debatable topic for free GRACE webinar, 4/7: what should be standard for molecular marker testing in NSCLC? http://bit.ly/bsrGOl
Advertisement
Richard Just, MD
@chemosabe1
RT .@ACCCBuzz: oncologists who treat NSCLC.... Unique Performance Improvement CME program: impact patients nationwide! http://t.co/Bj1xG7yQ
12 months ago...